Cargando…
Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446379/ https://www.ncbi.nlm.nih.gov/pubmed/34539458 http://dx.doi.org/10.3389/fpsyt.2021.684445 |
_version_ | 1784568857573195776 |
---|---|
author | Imataka, George Yui, Kunio Shiko, Yuki Kawasaki, Yohei Sasaki, Hitomi Shiroki, Ryoichi Yoshihara, Shigemi |
author_facet | Imataka, George Yui, Kunio Shiko, Yuki Kawasaki, Yohei Sasaki, Hitomi Shiroki, Ryoichi Yoshihara, Shigemi |
author_sort | Imataka, George |
collection | PubMed |
description | The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers, (1) hexanoyl-lysine (HEL), which is a new biomarker of oxidative stress, (2) the total antioxidant capacity (TAC), and (3) 8-hydroxy-2′-deoxyguanosine (8-OHdG), as a product of oxidative modifications to DNA; and the plasma levels of (4) the antioxidant protein superoxide dismutase (SOD), which is the crucial defense again oxygen reactive species, and (5) transferrin and (6) ceruloplasmin, which are biomarkers of iron and copper neurotransmission and oxidant-antioxidant systems. We examined the relationship between these urinary and plasma biomarkers and behavioral symptoms in 19 individuals with ASD (mean age, 10.8 ± 5.2 years) and 10 age-matched healthy controls (mean age, 14.2 ± 7.0 years). Behavioral symptoms were estimated using the Aberrant Behavior Checklist (ABC). Urinary TAC levels were significantly lower, whereas urinary HEL levels were significantly increased in the ASD group as compared with the control group. The five ABC subscale and total scores were significantly raised in the autism group than in the control group. The results of a linear regression analysis revealed that plasma SOD levels may be a more accurate predictor of differences in ABC scores between individuals with ASD and control individuals. The present study firstly revealed the important findings that the cooperation between the urinary antioxidant TAC and plasma SOD levels may contribute to the ABC subscale scores of stereotypy. Urinary TAC activity and antioxidant protein SOD may be associated with incomplete mineral body store and antioxidant-related transcription factor and browning reactions. Consequently, a critical imbalance between TAC urinary levels and plasma SOD levels may be an important contributor to autistic behavioral symptoms. |
format | Online Article Text |
id | pubmed-8446379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84463792021-09-18 Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder Imataka, George Yui, Kunio Shiko, Yuki Kawasaki, Yohei Sasaki, Hitomi Shiroki, Ryoichi Yoshihara, Shigemi Front Psychiatry Psychiatry The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers, (1) hexanoyl-lysine (HEL), which is a new biomarker of oxidative stress, (2) the total antioxidant capacity (TAC), and (3) 8-hydroxy-2′-deoxyguanosine (8-OHdG), as a product of oxidative modifications to DNA; and the plasma levels of (4) the antioxidant protein superoxide dismutase (SOD), which is the crucial defense again oxygen reactive species, and (5) transferrin and (6) ceruloplasmin, which are biomarkers of iron and copper neurotransmission and oxidant-antioxidant systems. We examined the relationship between these urinary and plasma biomarkers and behavioral symptoms in 19 individuals with ASD (mean age, 10.8 ± 5.2 years) and 10 age-matched healthy controls (mean age, 14.2 ± 7.0 years). Behavioral symptoms were estimated using the Aberrant Behavior Checklist (ABC). Urinary TAC levels were significantly lower, whereas urinary HEL levels were significantly increased in the ASD group as compared with the control group. The five ABC subscale and total scores were significantly raised in the autism group than in the control group. The results of a linear regression analysis revealed that plasma SOD levels may be a more accurate predictor of differences in ABC scores between individuals with ASD and control individuals. The present study firstly revealed the important findings that the cooperation between the urinary antioxidant TAC and plasma SOD levels may contribute to the ABC subscale scores of stereotypy. Urinary TAC activity and antioxidant protein SOD may be associated with incomplete mineral body store and antioxidant-related transcription factor and browning reactions. Consequently, a critical imbalance between TAC urinary levels and plasma SOD levels may be an important contributor to autistic behavioral symptoms. Frontiers Media S.A. 2021-09-03 /pmc/articles/PMC8446379/ /pubmed/34539458 http://dx.doi.org/10.3389/fpsyt.2021.684445 Text en Copyright © 2021 Imataka, Yui, Shiko, Kawasaki, Sasaki, Shiroki and Yoshihara. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Imataka, George Yui, Kunio Shiko, Yuki Kawasaki, Yohei Sasaki, Hitomi Shiroki, Ryoichi Yoshihara, Shigemi Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder |
title | Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder |
title_full | Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder |
title_fullStr | Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder |
title_full_unstemmed | Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder |
title_short | Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder |
title_sort | urinary and plasma antioxidants in behavioral symptoms of individuals with autism spectrum disorder |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446379/ https://www.ncbi.nlm.nih.gov/pubmed/34539458 http://dx.doi.org/10.3389/fpsyt.2021.684445 |
work_keys_str_mv | AT imatakageorge urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder AT yuikunio urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder AT shikoyuki urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder AT kawasakiyohei urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder AT sasakihitomi urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder AT shirokiryoichi urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder AT yoshiharashigemi urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder |